Pancreas Zn Research Articles

Comparison of zinc bioavailability in zinc-glycine and zinc-methionine chelates for broilers fed with a corn-soybean meal diet.

The objective of this study was to compare the bioavailability of zinc (Zn) from zinc-glycine (Zn-Gly) and zinc-methionine (Zn-Met) as compared with zinc sulfate (ZnSO4) used as a standard in broilers. A total of 1,200 one-day-old male broilers (Cobb 500) were randomly allotted to one of 10 treatments with eight replicate cages of 15 birds each. The broilers were fed a corn-soybean meal basal diet (containing 26.46mg Zn/kg; control) or the basal diet added with 40, 80, and 120mg Zn/kg as Zn-Gly, Zn-Met, or ZnSO4 for 14days. The relative bioavailability value (RBV) was calculated based on multiple linear regression slope ratios of Zn concentrations in tibia and pancreas, pancreas metallothionein (MT) concentration, and pancreas MT mRNA abundance on added Zn intake. When comparing the control with all Zn-supplemented treatments, Zn addition did not significantly affect average feed intake and bodyweight gain during days 1-14 (p > 0.10). However, Zn concentrations in the tibia, pancreas, and liver and pancreas MT concentration and MT mRNA abundance increased in all Zn-supplemented treatments compared with the control (p < 0.05), and these indices increased linearly (p < 0.001) with increasing added Zn levels on days 7 and 14. The RBV of Zn as Zn-Met was similar to that as Zn-Gly or ZnSO4 (p > 0.40) on days 7 and 14, based on tibia and pancreas Zn. In contrast, on days 7 and 14, the RBVs of Zn were in the following order: Zn-Met > Zn-Gly > ZnSO4 (p < 0.05), based on pancreas MT concentration. The bioavailable Zn from Zn-Met was 1.20 or 1.25 times that from Zn-Gly on day 7 or 14, respectively, evaluated by pancreas MT content. The RBV of Zn as Zn-Met was similar to that as Zn-Gly or ZnSO4 on day 7, whereas it was higher than that as Zn-Gly or ZnSO4 on day 14, based on pancreas MT mRNA abundance. In conclusion, Zn-Met had higher bioavailable Zn than Zn-Gly for the starter broilers fed with the corn-soybean meal diet, using pancreas MT concentration as the response criterion.

Effects of Zinc Sources and Levels on Growth Performance, Zinc Status, Expressions of Zinc Transporters, and Zinc Bioavailability in Weaned Piglets.

Simple SummaryBioavailability of inorganic zinc in animals is low, and large amounts of zinc are excreted into feces, resulting in potential negative impacts on the environment and waste of zinc resources. To reduce zinc supplementation in animal feed, prepared and characterized chitosan–zinc (CS–Zn) chelate was studied to investigate its bioavailability. Dietary CS–Zn improved the weight gain of weaned piglets as compared to ZnSO4. The Zn source had a significant influence on the liver, pancreas Zn contents, and the protein expression of ZnT1 and ZIP5 in duodenal mucosa. The Zn contents in the liver and pancreas and the protein expressions of ZnT1 and ZIP5 increased linearly with increases in the added Zn level. Multiple linear regression and the slope-ratio methodology showed that the bioavailability of CS–Zn was 110.9% or 149.0% relative to ZnSO4, respectively, using zinc content in the liver or pancreas as the response parameter. These results indicate that CS–Zn shows enhanced bioavailability, suggesting a good potential substitute for inorganic zinc in animal nutrition.The present study was conducted to explore the bioavailability of chitosan–zinc chelate (CS–Zn) in weaned piglets, and its characteristics of prepared and oral safety were also involved. A total of 210 crossbred weaned piglets (Duroc × Landrace × Large White) with a mean body weight of 6.30 kg were randomly assigned into seven dietary treatments involving a 2 × 3 factorial arrangement with two Zn sources (CS–Zn and ZnSO4) and three levels of added Zn (50, 100, 150 mg Zn/kg) plus a Zn-unsupplemented control diet. The feeding trial lasted 42 days. The AFM image of CS–Zn showed a rougher appearance and smaller size particles. The changes in spectrum peaks evidenced the successful chelating of Zn2+ with chitosan. The XRD patterns revealed the formation of a new crystalline phase. Moreover, the oral acute toxicity test of CS–Zn showed no lethal effects on mice. Weaned piglets fed dietary CS–Zn showed improved weight gain and decreased diarrhea incidence. Additionally, the bioavailability of CS–Zn was higher than that of ZnSO4 in piglets. Taken together, these results indicate that the prepared CS–Zn chelate, with rough surface and crystalline phase, is non-toxic and show enhanced bioavailability.

Effects of Different Sources and Levels of Zinc on Growth Performance, Nutrient Digestibility, and Fur Quality of Growing-Furring Male Mink (Mustela vison)

The objective of this study was to investigate the effects of different sources and levels of zinc (Zn) on growth performance, nutrient digestibility, serum biochemical parameters, and fur quality in growing-furring male mink. Animals in the control group were fed a basal diet with no Zn supplementation. Mink in the other nine treatments were fed the basal diet supplemented with Zn from either grade Zn sulfate (ZnSO4·7H2O), Zn glycinate (ZnGly), or Zn pectin oligosaccharides (ZnPOS) at concentrations of either 100, 300, or 900mg Zn/kg dry matter. One hundred and fifty healthy 15-week-old male mink were randomly allocated to ten dietary treatments (n=15/group) for a 60-day trial from mid-September to pelting in December. Mink in the Zn-POS groups had higher average daily gain than those in the control group (P<0.05). Zn source slightly improved the feed/gain (P=0.097). N retention was increased by Zn addition (P<0.05). Mink supplemented with dietary Zn had higher (P<0.05) pancreas Zn level than the control group. Fur length was greater (P<0.05) in ZnGly and ZnPOS groups compared with the control. In addition, fur length and fur density increased (linear, P<0.05) with Zn supplementation in the diet. In conclusion, our data show that dietary Zn addition improves growth performance by increasing nitrogen retention and fat digestibility in growing-furring mink and Z-POS is equally bioavailable to mink compared to ZnGly.

Anti-hyperglycemic Effect of Long-Term Bis(hinokitiolato)zinc Complex ([Zn(hkt)&lt;sub&gt;2&lt;/sub&gt;]) Ingestion on Insulin Resistance and Pancreatic Islet Cells Protection in Type 2 Diabetic KK-A&lt;sup&gt;y&lt;/sup&gt; Mice

Zinc (Zn) is a trace element with anti-diabetes mellitus (anti-DM) effects. Zn complexes exhibit stronger insulin-like activity than Zn ions. Bis(hinokitiolato)zinc complex ([Zn(hkt)2]) was recently reported to be a potent anti-DM candidate. We examined the effects of [Zn(hkt)2] on insulin resistance and pancreatic islet cells through in vivo long-term ingestion studies. In an in vivo study, we performed 4-month long-term [Zn(hkt)2] administration experiments in KK-Ay mice as a type 2 DM animal model. Ingestion of [Zn(hkt)2] resulted in lower blood glucose levels compared with the non-treated KK-Ay mice (control group). Additionally, [Zn(hkt)2] treatment decreased plasma insulin concentration compared with that of the non-treated KK-Ay group. [Zn(hkt)2] treatment resulted in a significant suppression of islet cell enlargement and a significantly decreased number of insulin-positive cells compared with the non-treated KK-Ay control group. The [Zn(hkt)2] treatment group showed the increasing tendency in the amount of Zn levels in peripheral organs; liver, muscle, adipose, and pancreas, compared with the non-treated KK-Ay control group. However, the Zn level in the pancreas of the [Zn(hkt)2] treatment group did not show the significant increase compared with the non-treated KK-Ay control group. This accumulation of Zn in pancreas suggested that [Zn(hkt)2] mainly effects on the peripheral tissue, and [Zn(hkt)2] has the less effect on the pancreas directly. Thus, we concluded that [Zn(hkt)2] exerted the main effect on peripheral organs by ameliorating insulin resistance.

Relative bioavailability of tribasic zinc sulfate for broilers fed a conventional corn-soybean meal diet

An experiment was carried out to investigate the relative bioavailability of tribasic zinc (Zn) sulfate relative to Zn sulfate for broilers fed a conventional corn-soybean meal diet. A total of 504 1-d-old Arbor Acres commercial male chicks were randomly assigned by body weight of birds to one of seven treatments involving a 2×3 factorial arrangement with three levels of added Zn (30, 60, or 90 mg of Zn kg−1) and two Zn sources (tribasic Zn sulfate and Zn sulfate) plus a control with no added Zn for an experimental phase of 14 d. Plasma Zn, tibia ash Zn, pancreas Zn, and pancreas metallothionein (MT) messenger RNA (mRNA) were analyzed at 6 or 14 d of age post-hatching. The results showed that plasma Zn, tibia ash Zn, pancreas Zn, and pancreas MT mRNA increased linearly (P<0.002) as dietary Zn concentration increased at 6 or 14 d of age. The R2 for a linear model was greater on d 6 than on d 14 for the above 4 responsive criteria, and among these indices, the fitting of the tibia ash Zn concentration was the best (R2=0.99). Therefore, based on slope ratios from the multiple linear regressions of the above 4 indices of the birds at 6 d of age on daily intake of dietary Zn, the bioavailabilities of tribasic Zn sulfate relative to Zn sulfate (100%) were 95.6% (P=0.18), 83.5% (P=0.01), 87.9% (P=0.53), and 75.9% (P=0.38) for the tibia ash Zn, pancreas Zn, plasma Zn, and pancreas MT mRNA, respectively. The results indicated that generally, Zn from tribasic Zn sulfate was as available as Zn from Zn sulfate for broilers.

Relative bioavailability of zinc-methionine chelate for broilers fed a conventional corn-soybean meal diet.

An experiment was carried out to determine the bioavailability of the organic Zn-methionine chelate relative to inorganic Zn source (ZnSO4•7H2O) for broiler chicks fed a conventional corn-soybean meal diet. A total of 504 1-day-old Arbor Acres commercial male broiler chicks were randomly allotted to one of seven treatments in a completely randomized design involving a 2 × 3 factorial arrangement with three levels of added Zn (30, 60, or 90 mg of Zn/kg) and two Zn sources (Zn-methionine chelate and Zn sulfate) plus a Zn-unsupplemented control diet containing 29.2 mg of Zn/kg by analysis for an experimental phase of 21 days. Bone and pancreas were collected for testing Zn concentrations and pancreas metallothionein (MT) messenger RNA (mRNA) level at 7 or 21 days of age. The results showed that bone and pancreas Zn concentrations and MT mRNA level in pancreas increased linearly (P < 0.0001) at 7 or 21 days of age as added Zn level increased. Based on slope ratios from multiple linear regressions of the pancreas, MT mRNA level at 7 days and pancreas Zn concentration at 21 days on added Zn level and the bioavailability values of the Zn-methionine chelate relative to ZnSO4•7H2O (100%) were 120 and 115%, respectively (P > 0.22). The results indicated that the Zn from the Zn-methionine chelate was just as bioavailable as the Zn from Zn sulfate for broilers.

Effect of weaning and in‐feed high doses of zinc oxide on zinc levels in different body compartments of piglets

High doses of Zn are widely used for prevention and treatment of diarrhoea in weaning piglets; however, the mechanism of action of Zn against diarrhoea is still not well understood. The objective of this study was to evaluate whether weaning induces Zn deficiency in piglets. Eight litters of primiparous sows were selected for the experiment, and 3 piglets presenting similar weights were selected within each litter. Two of the three selected piglets from each litter were weaned at 21d of age and fed two different diets: a commercial control diet (WCt) and the same diet plus 2000 ppm of Zn as ZnO (WZn). The third selected pig from each litter was kept unweaned (Uw) with the sow and the rest of the litter. All 24 selected animals were killed at 28 d of age, and blood, gastrointestinal content, liver, pancreas and spleen were sampled for Zn, Fe and Cu analysis (mg/kg or L of sample). Data were analysed using anova including treatment as a fixed factor. Weaned pigs fed WCt diet presented a lower Zn concentration in plasma than Uw animals (0.76 ± 0.091 vs. 1.10 ± 0.099 mg/L, p = 0.05). Zinc levels in liver, pancreas and spleen were not affected by weaning. Total concentration of Zn was higher in gastrointestinal contents of weaned animals fed WCt diet than in Uw pigs (p ≤ 0.001 for stomach, jejunum, ileum, caecum and colon). Supplementation with high doses of ZnO increased levels of Zn in gastrointestinal content (p < 0.001), liver (p < 0.001) and pancreas (p < 0.001) compared to WCt diet. It also increased plasma Zn to non-deficient levels (1.32 ± 0.086), but the increase was not as marked as in other locations and final concentration was not different than that in Uw animals (p = 0.231). Weaning creates a Zn deficiency situation in weaned pigs as observed by plasma Zn concentrations. ZnO supplementation counteracts Zn deficiency.

Effect of intravenously injected zinc on tissue zinc and metallothionein gene expression of broilers

1. The effect of intravenously injected zinc (Zn) on tissue Zn concentrations and pancreas metallothionein (MT) gene expression in broilers was investigated to detect differences in the tissue utilisation of Zn from different Zn sources. 2. A total of 432 male chickens were randomly allotted on d 22 post-hatch to one of nine treatments in a completely randomised design. Chickens were injected with either a 0.9% (w/v) NaCl solution (control) or a saline solution supplemented with Zn sulphate or one of three organic Zn chelates with weak (Zn-AA W), moderate (Zn-Pro M) or strong (Zn-Pro S) chelation strengths at two injected Zn dosages calculated according to two Zn absorbability levels (6 and 12%). 3. Bone and pancreas Zn concentrations, pancreas MT mRNA levels and MT concentrations increased on d 6 and 12 after Zn injections as the injected Zn dosages increased. Chickens injected with the Zn-Pro S had lower bone Zn concentration than those injected with the Zn-Pro M or Zn-AA W on d 6 after injections. However, no differences among Zn sources were observed in bone Zn concentration on d 12 after injections, pancreas Zn concentrations, pancreas MT mRNA levels and MT concentrations on both d 6 and d 12 after injections. 4. It was concluded that the injected Zn-Pro S was the least favourable for bone Zn utilisation of broilers. The pancreas Zn concentration and pancreas MT gene expressions might not be sensitive enough to detect differences in the tissue utilisation of injected Zn in broilers between organic and inorganic Zn sources or among organic Zn sources.

Optimal dietary zinc levels of broiler chicks fed a corn–soybean meal diet from 22 to 42 days of age

An experiment was conducted to investigate the effect of dietary zinc (Zn) level on growth performance, Zn concentration, Zn metalloenzyme activity, Zn transporter 2 (ZnT2) mRNA abundance, metallothionein (MT) mRNA abundance and MT concentration in either serum or tissues, so as to evaluate the optimal dietary Zn level of broiler chicks fed a corn–soybean meal diet from 22 to 42 days of age. At 22 days of age, 288 birds were assigned randomly by bodyweight to one of eight dietary treatments of six replicate cages each with six birds per cage, and fed a Zn-unsupplemented basal corn–soybean meal diet containing 27.66 mg of Zn/kg or the basal diet supplemented with 20, 40, 60, 80, 100, 120 or 140 mg of Zn/kg from reagent-grade ZnSO4·7H2O. Regression analysis was performed to estimate the optimal dietary Zn level in the presence of asymptotic response. The results showed that dietary Zn level had no effect (P &gt; 0.25) on the growth performance, serum alkaline phosphatase and 5′-nucleotidase activities, and liver copper-Zn superoxide dismutase activity, but affected (P &lt; 0.07) tibia Zn concentration, pancreas Zn concentration, ZnT2 mRNA abundance, MT mRNA abundance and MT concentration. The optimal dietary Zn requirements of broilers from 22 to 42 days of age were 62.44 mg/kg for tibia Zn, 64.30 mg/kg for ZnT2 mRNA abundance and 53.50 mg/kg for MT mRNA abundance based on asymptotic models, respectively. Accordingly, the optimal dietary Zn level for broilers from 22 to 42 days of age was 65 mg/kg in this study.

Relative bioavailabilities of organic zinc sources with different chelation strengths for broilers fed a conventional corn-soybean meal diet1

An experiment was conducted to estimate relative bioavailability of Zn in 3 organic zinc sources with different chelation strength (Q(f)) compared with ZnSO(4). A total of 1,092, 1-d-old male broiler chicks were assigned randomly to 6 replicate cages (14 chicks per cage) for each of 13 treatments. Dietary treatments included the basal corn-soybean meal diet (27.82 mg of Zn/kg of DM) supplemented with 0, 30, 60, or 90 mg of added Zn as reagent ZnSO(4), or Zn sources with Q(f) of 6.5 (11.93% Zn; Zn AA C), 30.7 (13.27% Zn; Zn Pro B), or 944.0 (18.61% Zn; Zn Pro A)/kg, which are considered as weak, moderate, or strong Q(f), respectively. Bone Zn, pancreas Zn, pancreas metallothionein (MT) concentration, and pancreas MT messenger RNA (mRNA) were analyzed at 6, 10, or 14 d of age. The results showed that bone Zn, pancreas Zn, pancreas MT concentration, and pancreas MT mRNA increased linearly (P < 0.001) as dietary Zn concentration increased at all ages. At 6 d of age, pancreas MT mRNA differed (P < 0.001) among dietary Zn sources, and the same tendency was observed at 10 (P = 0.08) or 14 d (P = 0.06) of age. The R(2) for a linear model was greater on d 6 than d 10 or 14 for all the response criteria. Based on slope ratios from the multiple linear regression of pancreas MT mRNA concentration on daily intake of dietary Zn, the bioavailability of Zn AA C, Zn Pro B, and Zn Pro A relative to ZnSO(4) (100%) were 100.0, 121.1, and 72.3%, respectively, at 6 d of age. The results indicated that MT mRNA concentration in pancreas was more sensitive in reflecting differences in bioavailability among organic Zn sources than the MT concentration in pancreas or other indices. Moreover, the bioavailability of organic Zn sources was closely related to their Q(f).

Age-Related Changes in Tissue and Plasma Zinc Levels: Modulation by Exogenously Administered Melatonin

Melatonin (MEL) is synthesized mainly in the pineal gland and derived from 5-hydroxytryptophan (5-HTP). Zinc (Zn) is one of the most important trace elements in the body. Zn and MEL levels are changed with aging. The aim of this study was to investigate the age-related changes of tissue and plasma Zn levels and effect of MEL administration on these parameters. Male wistar rats received for 3 weeks subcutaneous injection of MEL (10 mg/kg). Kidney and pancreas Zn levels in old rats were significantly lower than middle-aged group. Spleen, small intestine, and plasma Zn levels were not different in middle-aged and old rats. On the other hand, MEL treatment increased Zn levels of small intestine and plasma in middle-aged rats. However, kidney, spleen, and pancreas Zn levels were unaffected by MEL treatment.

An Optimal Dietary Zinc Level of Broiler Chicks Fed a Corn-Soybean Meal Diet

An experiment was conducted to estimate the optimal dietary zinc level for broiler chicks fed a corn-soybean meal diet. A total of 384 one-day-old male broiler chicks were assigned randomly to dietary treatments for 21 d. These treatments included a basal corn-soybean meal diet (28.32 mg of Zn/kg) supplemented with 0, 20, 40, 60, 80, 100, 120, or 140 mg of Zn/kg in the form of reagent-grade ZnSO4·7H2 O. All treatments were replicated 6 times using 8 chicks per pen. Tissue Zn concentration, Zn metalloenzyme activity, metallothionein (MT) concentration, MT mRNA level, and Zn transporter-2 (ZnT-2) mRNA level were analyzed for choosing suitable criterion to determine the optimal dietary Zn level for broilers. Regression analysis was performed to estimate optimal dietary Zn level in the presence of quadratic or asymptotic responses. Results showed that weight gain and feed intake were increased with dietary Zn level (P < 0.05), and the maximum weight gain and feed intake were observed in the diet supplemented with 20 mg of Zn/kg (48.37 mg/kg, total dietary Zn). Pancreas MT and MT mRNA increased linearly with Zn supplementation. According to the asymptotic model, the optimal Zn requirement of chicks from hatch to 21 d of age was 59.15 mg/kg for pancreas Zn and 61.70 mg/kg for bone Zn respectively. Quadratic responses were exhibited by serum 5′-nucleotidase activity and pancreas Zn transporter-2 mRNA level, resulting in total optimal dietary levels of 80.50 and 84.09 mg/kg, respectively. Based on results from this study, the optimal dietary Zn level of chicks from hatch to 21 d of age is 84 mg/kg.

Marginal zinc deficiency in rats decreases leptin expression independently of food intake and corticotrophin-releasing hormone in relation to food intake

Zn deficiency reduces food intake and growth rate in rodents. To determine the relationship between Zn deficiency and the regulation of food intake, we evaluated leptin gene expression in epididymal white adipose tissue (eWAT), and hypothalamic corticotropin-releasing hormone (hCRH) and hypothalamic neuropeptide Y (hNPY) of rats Zn-deficient only to show reduced food intake and growth rate but not food intake cycling. Growing male Sprague-Dawley rats (240 g) were randomly assigned to one of four dietary groups: Zn-adequate (ZA; 30 mg/kg diet), Zn-deficient (ZD; 3 mg/kg diet), pair-fed with ZD (PF; 30 mg/kg diet) and Zn-sufficient (ZS; 50 mg/kg diet) (n 8), and were fed for 3 weeks. Food intake and body weight were measured, as were blood mononuclear cells and pancreas Zn levels. eWAT leptin, hCRH and hNPY mRNA levels were determined. Food intake was decreased by about 10 % in ZD and PF rats compared to ZA and ZS rats. Growth and eWAT leptin mRNA levels were unaffected in PF rats but were significantly (P < 0.05) decreased in ZD rats. However, hNPY showed a tendency to increase, and hCRH significantly (P < 0.05) decreased, in both ZD and PF rats. These results suggest that while leptin gene expression may be directly affected by Zn, hNPY and hCRH are likely responding to reduced food intake caused by Zn deficiency.

Coxsackievirus B3 Infection Affects Metal-Binding/Transporting Proteins and Trace Elements in the Pancreas in Mice

The trigger of juvenile diabetes has been suggested to be an interaction between a virus and trace elements, where enteroviruses, including coxsackievirus B3 (CVB3), have been discussed as potential initiators. The aim of this study was to investigate the effects in the pancreas on gene expressions of metallothionein 1 (MT1), divalent metal transporter 1 (DMT1), and zinc transporter 5 (ZnT-5) and concomitant changes in iron (Fe), copper (Cu), and zinc (Zn) in serum and pancreas of Balb/c mice on days 3, 6, and 9 of CVB3 infection. Trace elements were measured through inductively coupled plasma-mass spectrometry, and CVB3, MT1, DMT1, and ZnT-5 were measured by reverse transcription-polymerase chain reaction. Virus was found in the pancreas on all days, with a peak on day 3. Infection tended to increase Fe in both serum and the pancreas. The Cu/Zn ratio in the pancreas increased early in the infection because of a great decrease in Zn. In serum, the Cu/Zn ratio was not increased until day 9 of the disease. In the pancreas, MT1 decreased, whereas DMT1 tended to increase on day 6, and ZnT-5 increased progressively during the course of the disease. Virus-induced changes in trace elements, MT1, DMT1, and ZnT-5 in the pancreas may reflect early stages of the development of pancreatitis and prestages of diabetic disease.

Growth and intestinal morphology of pigs from sows fed two zinc sources during gestation and lactation1,2

An experiment was conducted to compare the effects of organic (Zn AA complex, ZnAA) and inorganic Zn (ZnSO4) sources on sows and their progeny during gestation and lactation and on the pigs during the nursery period. The dietary treatments were 1) a corn-soybean meal diet with 100 ppm Zn from ZnSO4 (control); 2) diet 1 + 100 ppm additional Zn from ZnSO4; and 3) diet 1 + 100 ppm additional Zn from ZnAA. Dietary additions were on an as-fed basis. Thirty-one primaparous and multiparous sows were allotted to the treatment diet beginning on d 15 of gestation and continuing through lactation. At weaning (d 17 of age), 202 pigs (63, 55, and 84 pigs for treatments 1 to 3, respectively) were allotted to the same dietary treatment as their dam. The pigs were fed a 3-phase diet regimen during the nursery period: d 0 to 7 (phase I); d 7 to 21 (phase II); and d 21 to 28 (phase III). At weaning and at the end of phase III, 1 gilt per replicate was killed, and the left front foot, liver, pancreas, and entire small intestine were removed. Diet had no effect (P > 0.10) on any response during gestation. During lactation, there was an increase (P < 0.10) in litter birth weight in sows fed ZnAA compared with those fed the control or ZnSO4 diets. The sows fed ZnAA nursed more pigs (P < 0.10) than sows fed the ZnSO4 diet, and they weaned more pigs (P < 0.05) than sows fed the control diet. Jejunal villus height of the weaned pigs from sows fed ZnSO4 was increased (P < 0.05) compared with those from the sows fed the control diet. During the nursery period, growth performance was not affected (P > 0.10) by diet. Pigs fed ZnSO4 had greater duodenal villus width (P < 0.05) than those fed ZnAA, and pigs fed ZnSO4 or the control diet had greater ileal villus width (P < 0.05) than those fed ZnAA. Pigs fed ZnSO4 or ZnAA had more (P < 0.05) bone Zn than those fed the control diet. Liver Zn concentration was greatest in pigs fed ZnSO4, followed by those fed ZnAA, and then by those fed the control diet (P < 0.05). Pancreas Zn was increased (P < 0.05) in pigs fed ZnSO4 compared with those fed the control diet. These results suggest that 100 ppm Zn in trace mineral premixes provides adequate Zn for optimal growth performance of nursery pigs, but that 100 ppm additional Zn from ZnAA in sow diets may increase pigs born and weaned per litter.

Chemical characteristics and relative bioavailability of supplemental organic zinc sources for poultry and ruminants.

Eight commercially available organic Zn products and reagent-grade ZnSO4 x 7H2O (Zn Sulf) were evaluated by polarographic analysis, and solubility in .1 M K2HPO4-KH2PO4 buffer (pH 5), .2 M HCl-KCl buffer (pH 2), and deionized water. Fractions from these solubility tests were evaluated by gel filtration chromatography for structural integrity. Degree of chelation was generally positively related to chelation effectiveness determined by polarography. The organic sources were Zn methionine complex A (Zn MetA), Zn methionine complex B (Zn MetB), Zn polysaccharide complex (Zn Poly), Zn lysine complex (Zn Lys), Zn amino acid chelate (Zn AA), Zn proteinate A (Zn ProA), Zn proteinate B (Zn ProB), and Zn proteinate C (Zn ProC). Three experiments were conducted to estimate the relative bioavailability of Zn from the organic Zn supplements for chicks and lambs when added at high dietary levels to practical diets. Bone Zn concentration increased (P < .001) as dietary Zn increased in both experiments. When Zn Sulf was assigned a value of 100% as the standard, multiple linear regression slope ratios of bone Zn from chicks fed 3 wk regressed on dietary Zn intake gave estimated relative bioavailability values of 83 +/- 14.6 and 139 +/- 16.9 for Zn AA and Zn ProA, respectively, in Exp. 1 and 94 +/- 11.6, 99 +/- 8.8, and 108 +/- 11.4 for Zn Poly, Zn ProB, and Zn ProC, respectively, in Exp. 2. In Exp. 3, 42 lambs were fed diets containing Zn Sulf, Zn ProA, Zn AA, or Zn MetB for 21 d. Based on multiple linear regression slope ratios of liver, kidney, and pancreas Zn and liver metallothionein concentrations on added dietary Zn, bioavailability estimates relative to 100% for Zn Sulf were 130, 110, and 113 for Zn ProA, Zn AA, and Zn MetB, respectively. Except for Zn ProA, which was greater, the organic Zn supplements had bioavailability values similar to that of Zn Sulf for chicks and lambs. Bioavailability of organic Zn products was inversely related to solubility of Zn in pH 5 buffer in chicks (r2 = .91) and pH 2 buffer in lambs (r2 = .91), but not to an estimate of degree of chelation.

Estimation of the relative bioavailability of zinc from inorganic zinc sources for sheep

Two experiments were conducted to study bioavailability of reagent (RG) and feed (FG) grade sources of Zn for sheep based on tissue Zn uptake and liver metallothionein (MT) concentration. In both experiments, 42 crossbred wether lambs were given a practical basal diet containing 44 mg kg −1 Zn (Exp. 1) or 64 mg kg −1 Zn (Exp. 2) for a 7 day adjustment period followed by experimental diets for 23 days. In Exp. 1, the basal diet was supplemented with 0, 700, 1400, or 2100 mg kg −1 Zn as RG ZnSO 4 · 7H 2O (standard) or 1400 mg kg −1 Zn as RG Zn basic carbonate, Zn oxide, or metallic Zn. Based on multiple linear regression slope ratios of log 10 transformed accumulation of Zn in pancreas, liver and kidney on dietary Zn concentration, relative bioavailability estimates were sulfate 100, carbonate 106, oxide 106, and metal 76. In Exp. 2, added concentrations were the same and sources were FG sulfate-A (standard) or FG sulfate-B, oxide-A, and oxide-B. Bioavailability estimates on the same basis were 100, 86, 87, and 79 respectively. Use of liver MT as the response criterion gave estimates of 100, 88, 88, and 77 respectively.

The role of the pancreas in the regulation of zinc status

A low Zn diet resulted in subacute Zn deficiency in young rats. Thirty minutes after the intubation of a trace 65-Zn we determined the total tissue Zn activity in plasma, erythrocytes, liver, pancreas, bone, muscle, and proximal jejunum. Assuming the body behaved like a closed multicompartmental system in steady state, we estimated the initial Zn exchange between plasma, and the erythrocytes or these tissues. In comparison with control animals the exchanges between plasma and erythrocytes or pancreas increased threefold during subacute Zn deficiency. In the pancreas the ratio also reversed from < 1.0 to > 1.0. This confirmed earlier observations that the specific activity (kBq 65-Zn/mol Zn) increased mostly in the pancreas. By increased net Zn uptake during subacute deficiency, the pancreas Zn content remained constant in chronic Zn deficiency. We discussed the regulation of the Zn status by the pancreas. We hypothesize that the exocrine pancreas modulates Zn absorption by an exocrine ligand that enhances absorption in the jejunum during subacute deficiency: Unsaturated with Zn it binds dietary intraluminal Zn and increases the Zn absorption. The literature provides evidence in confirmation. This hypothesis explains also conflicting data on the inherited Zn malabsorption syndrome Acrodermatitis Enteropathica.

Effect of Dietary Sodium Zeolite A on Zinc Utilization by Chicks

Two experiments were conducted with chicks from 5 to 15 days posthatching to study the effect of sodium zeolite A (SZA) on Zn utilization. The corn-soybean meal basal diet was supplemented with ZnCO3 to provide three levels of dietary Zn (35, 40, and 85 ppm) in Experiment 1, and two levels of dietary Zn (85 and 4,000 ppm) in Experiment 2. Experimental diets also contained either 0 or .75% SZA, resulting in a 3 × 2 and a 2 × 2 factorial arrangement of treatments in Experiments 1 and 2, respectively. The tendency for increased growth, feed intake, and hematocrit in chicks fed Zn-supplemented diets in Experiment 1 suggests that the 35-ppm level of Zn in the basal diet was marginal for chicks. Both supplemental Zn and SZA increased (P < .02) hematocrit and plasma, pancreas, and tibia Zn and decreased (P < .02) tibia Cu. Sodium zeolite A increased (SZA by Zn, P < .03) tibia Al and tended to increase (SZA by Zn, P < .09) liver Fe in chicks fed either 35 or 85 ppm Zn, but SZA had no effect on tibia Al and liver Fe in chicks fed 40 ppm Zn. In Experiment 2, both SZA and excess dietary Zn decreased gain, feed intake, gain: feed, hematocrit, hemoglobin, and plasma alkaline phosphatase (AP) activity, and increased tibia, liver, and pancreas Zn, and tibia Al. In addition, excess Zn increased (P < .05) plasma Zn and liver Al but decreased (P < .01) plasma, liver, and pancreas Cu and percentage of tibia ash. The addition of SZA enhanced the adverse effects of excess Zn by further decreasing feed intake, hematocrit, hemoglobin, and plasma AP and Cu and by increasing tibia Al and liver Zn. Sodium zeolite A increased pancreas (P < .09) and tibia (P < .03) Zn regardless of dietary Zn concentration; however, SZA increased plasma Zn only in chicks fed 85 ppm Zn (SZA by Zn, P < .03). Sodium zeolite A tended to improve Zn utilization in chicks fed inadequate Zn but exacerbated the adverse effects of feeding excess Zn. The addition of SZA to the diet of chicks fed inadequate, adequate, or toxic levels of Zn resulted in increased tissue Zn concentration.

Short-Term High Level Zinc Feeding and Tissue Zinc Concentration in Mature Laying Hens

Two trials were conducted to study the effects of high dietary Zn on tissue Zn accumulation and depletion in laying hens. Hens laying at approximately 60 to 70% were fed a diet containing 20 g Zn as ZnO/kg diet (as fed) for 4 days. For the remaining 18 days, hens were fed the same diet without the 20 g added Zn/kg diet. Ten hens were killed at initiation of the experiment (Day 0), and liver, kidney, and pancreas were obtained for Zn analysis. On Days 1, 2, 3, 4, 10, 16, and 22, similar samples were obtained from 10 hens.Feeding high Zn for 4 days caused a reduction in ovary and oviduct weight by Day 10. Liver, kidney and pancreas Zn concentrations increased approximately 10, 3, and 25-fold, respectively, in birds following 4 days of feeding the high Zn diets. The liver and kidney Zn concentrations returned to pretreatment concentrations within 18 days after the birds were fed the control diets (Day 22). The pancreas maintained higher Zn concentrations in comparison with the other tissues following withdrawal of the high Zn diet.